Safe and effective barrier against contamination during TSCPC

Article

Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients.

Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients, according to a study published in the Journal of Glaucoma.

An investigation led by Dr Daniel B. Rootman, University of Toronto, Canada, measured diode laser output with and without the G-probe barrier both pre- and post- TSCPC. After each test, the barrier was inspected for microperforations and debris. Microbiology was recorded on the cadaver eye and after 20 cycles of the G-probe.

It was found that there was a statistically significant difference between the diode laser output with and without the G-probe barrier both pre- and post- TSCPC and the laser focus dispersion was reduced by the G-probe cover.

However, when using the G-probe barrier the clinicians found no evident perforations or any debris on the G-probe post-treatment.

Therefore, it was concluded that use of the barrier was effective when trying to avoid contamination during TSCPC.

Recent Videos
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
© 2024 MJH Life Sciences

All rights reserved.